These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Iontophoretic delivery of lipophilic and hydrophilic drugs from lipid nanoparticles across human skin. Charoenputtakun P, Li SK, Ngawhirunpat T. Int J Pharm; 2015 Nov 10; 495(1):318-328. PubMed ID: 26325320 [Abstract] [Full Text] [Related]
5. Cutaneous penetration of soft nanoparticles via photodamaged skin: Lipid-based and polymer-based nanocarriers for drug delivery. Hung CF, Chen WY, Hsu CY, Aljuffali IA, Shih HC, Fang JY. Eur J Pharm Biopharm; 2015 Aug 10; 94():94-105. PubMed ID: 25986584 [Abstract] [Full Text] [Related]
6. Lipid nanoparticles as carrier for octyl-methoxycinnamate: in vitro percutaneous absorption and photostability studies. Puglia C, Bonina F, Rizza L, Blasi P, Schoubben A, Perrotta R, Tarico MS, Damiani E. J Pharm Sci; 2012 Jan 10; 101(1):301-11. PubMed ID: 21905033 [Abstract] [Full Text] [Related]
7. Fabrication, appraisal, and transdermal permeation of sildenafil citrate-loaded nanostructured lipid carriers versus solid lipid nanoparticles. Elnaggar YS, El-Massik MA, Abdallah OY. Int J Nanomedicine; 2011 Jan 10; 6():3195-205. PubMed ID: 22238508 [Abstract] [Full Text] [Related]
8. Passive and active strategies for transdermal delivery using co-encapsulating nanostructured lipid carriers: in vitro vs. in vivo studies. Vitorino C, Almeida A, Sousa J, Lamarche I, Gobin P, Marchand S, Couet W, Olivier JC, Pais A. Eur J Pharm Biopharm; 2014 Feb 10; 86(2):133-44. PubMed ID: 24333401 [Abstract] [Full Text] [Related]
9. Impact of lipid dynamic behavior on physical stability, in vitro release and skin permeation of genistein-loaded lipid nanoparticles. Andrade LM, de Fátima Reis C, Maione-Silva L, Anjos JL, Alonso A, Serpa RC, Marreto RN, Lima EM, Taveira SF. Eur J Pharm Biopharm; 2014 Sep 10; 88(1):40-7. PubMed ID: 24816130 [Abstract] [Full Text] [Related]
10. Comparison of liposomal and NLC (nanostructured lipid carrier) formulations for improving the transdermal delivery of oxaprozin: Effect of cyclodextrin complexation. Mennini N, Cirri M, Maestrelli F, Mura P. Int J Pharm; 2016 Dec 30; 515(1-2):684-691. PubMed ID: 27825863 [Abstract] [Full Text] [Related]
11. Tadalafil-loaded nanostructured lipid carriers using permeation enhancers. Baek JS, Pham CV, Myung CS, Cho CW. Int J Pharm; 2015 Nov 30; 495(2):701-9. PubMed ID: 26423175 [Abstract] [Full Text] [Related]
12. Lipid nanoparticles as vehicles for topical psoralen delivery: solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC). Fang JY, Fang CL, Liu CH, Su YH. Eur J Pharm Biopharm; 2008 Oct 30; 70(2):633-40. PubMed ID: 18577447 [Abstract] [Full Text] [Related]
14. Development of SLNs from natural lipids: application to topical delivery of tretinoin. Mandawgade SD, Patravale VB. Int J Pharm; 2008 Nov 03; 363(1-2):132-8. PubMed ID: 18657601 [Abstract] [Full Text] [Related]
15. Resveratrol-loaded solid lipid nanoparticles versus nanostructured lipid carriers: evaluation of antioxidant potential for dermal applications. Gokce EH, Korkmaz E, Dellera E, Sandri G, Bonferoni MC, Ozer O. Int J Nanomedicine; 2012 Nov 03; 7():1841-50. PubMed ID: 22605933 [Abstract] [Full Text] [Related]
16. Development of ibuprofen-loaded nanostructured lipid carrier-based gels: characterization and investigation of in vitro and in vivo penetration through the skin. Sütő B, Berkó S, Kozma G, Kukovecz Á, Budai-Szűcs M, Erős G, Kemény L, Sztojkov-Ivanov A, Gáspár R, Csányi E. Int J Nanomedicine; 2016 Nov 03; 11():1201-12. PubMed ID: 27099487 [Abstract] [Full Text] [Related]
18. Lipid nanocapsules for dermal application: a comparative study of lipid-based versus polymer-based nanocarriers. Abdel-Mottaleb MM, Neumann D, Lamprecht A. Eur J Pharm Biopharm; 2011 Sep 03; 79(1):36-42. PubMed ID: 21558002 [Abstract] [Full Text] [Related]